Harbeck, N., & Gnant, M. (2017). Breast cancer. Lancet, 389(10074), 1134–1150.

Article  PubMed  Google Scholar 

Fackler, M. J., et al. (2020). DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer, 6, 3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lou, L., et al. (2018). c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo. Cancer Science, 109(5), 1648–1659.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, S., et al. (2018). LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death & Disease, 9(8), 805.

Article  Google Scholar 

Al-Mahmood, S., et al. (2018). Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research, 8(5), 1483–1507.

Article  PubMed  PubMed Central  Google Scholar 

Mao, L., et al. (2020). The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope? Cell Death & Disease, 11(7), 518.

Article  CAS  Google Scholar 

Chen, X., et al. (2021). Broadening horizons: the role of ferroptosis in cancer. Nature Reviews Clinical Oncology, 18(5), 280–296.

Article  CAS  PubMed  Google Scholar 

Chen, C., et al. (2022). Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis. Cell Death & Disease, 13(2), 150.

Article  CAS  Google Scholar 

Mo, A., et al. (2016). Association between polymorphisms of thymidylate synthase gene 5′- and 3′-UTR and gastric cancer risk: meta-analysis. Bioscience Reports, 36(6), e00429.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guijarro, M. V., et al. (2023). TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background. Oncogene, 42(23), 1926–1939.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, Q., et al. (2015). Prognostic and predictive significance of thymidylate synthase protein expression in non-small cell lung cancer: a systematic review and meta-analysis. Cancer Biomarkers, 15(1), 65–78.

Article  CAS  PubMed  Google Scholar 

Edler, D., et al. (2002). Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. Journal of Clinical Oncology, 20(7), 1721–1728.

Article  CAS  PubMed  Google Scholar 

Popat, S., Matakidou, A., & Houlston, R. S. (2004). Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. Journal of Clinical Oncology, 22(3), 529–536.

Article  CAS  PubMed  Google Scholar 

Zhou, Y. H., et al. (2019). Associations between clinical-pathological parameters and biomarkers, HER-2, TYMS, RRMI, and 21-gene recurrence score in breast cancer. Pathology – Research and Practice, 215(11), 152644.

Article  CAS  PubMed  Google Scholar 

Jie, Y., Yang, X., & Chen, W. (2021). Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining. PeerJ, 9, e11368.

Article  PubMed  PubMed Central  Google Scholar 

Liu, T., et al. (2019). MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription. EBioMedicine, 48, 289–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan, X., et al. (2015). Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤55 years. Molecular Carcinogenesis, 54(4), 281–290.

Article  CAS  PubMed  Google Scholar 

Lei, P., Bai, T., & Sun, Y. (2019). Mechanisms of ferroptosis and relations with regulated cell death: a review. Frontiers in Physiology, 10, 139.

Article  PubMed  PubMed Central  Google Scholar 

Stoyanovsky, D. A., et al. (2019). Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction? Free Radical Biology and Medicine, 133, 153–161.

Article  CAS  PubMed  Google Scholar 

Shui, S., et al. (2021). Non-enzymatic lipid peroxidation initiated by photodynamic therapy drives a distinct ferroptosis-like cell death pathway. Redox Biology, 45, 102056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sleire, L., et al. (2015). Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene, 34(49), 5951–5959.

Article  CAS  PubMed  Google Scholar 

Zhang, Z., et al. (2021). Holo-lactoferrin: The link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics, 11(7), 3167–3182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, Z., et al. (2020). Systematic analysis of the aberrances and functional implications of ferroptosis in cancer. iScience, 23(7), 101302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poser, S., et al. (2000). SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. The EMBO Journal, 19(18), 4955–4966.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Irusta, G., et al. (2013). Effects of an inhibitor of the γ-secretase complex on proliferation and apoptotic parameters in a FOXL2-mutated granulosa tumor cell line (KGN). Biology of Reproduction, 89(1), 9.

Article  PubMed  Google Scholar 

Li, J. Y., et al. (2014). The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. Journal of Bone and Mineral Research, 29(1), 43–54.

Article  PubMed  Google Scholar 

Yi, J., et al. (2020). Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proceedings of the National Academy of Sciences of the United States of America, 117(49), 31189–31197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, L., Wang, J., & Chen, L. (2023). TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway. Immunopharmacology and Immunotoxicology, 45(4), 419–425.

Article  CAS  PubMed  Google Scholar 

Lin, S., et al. (2019). Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer. Cancer Communications, 39(1), 57.

Article  PubMed  PubMed Central  Google Scholar